Premium
Letter: double‐dose intensification—a quick way to reverse antibody formation and loss of response in patients treated with adalimumab. Authors reply
Author(s) -
Ungar Bella,
Ben Horin Shomron,
Roblin Xavier
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15139
Subject(s) - medicine , adalimumab , tumor necrosis factor alpha
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom